Search - Université de Rennes Access content directly

Filter your results

32 Results
authFullName_s : Pierre Clavelou

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Xavier Ayrignac , Clarisse Carra Dallière , Nicolas Menjot de Champfleur , Christian Denier , Patrick Aubourg et al.
Brain - A Journal of Neurology , 2015, 138 (Pt 2), pp.284-92. ⟨10.1093/brain/awu353⟩
Journal articles hal-01138578v1
Image document

Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: the MusiCare Questionnaire

David Veillard , Karine Baumstarck , Gilles Edan , Marc Debouverie , Sandrine Wiertlewski et al.
European Journal of Neurology, 2021, 28 (3), pp.910-920. ⟨10.1111/ene.14685⟩
Journal articles hal-03101922v1

Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis

Izanne Roos , Emmanuelle Leray , Romain Casey , Dana Horakova , Eva Havrdova et al.
Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
Journal articles hal-03282036v1

Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference

Antoine Gavoille , Fabien Rollot , Romain Casey , Marc Debouverie , Emmanuelle Le Page et al.
Neurology, 2023, 100 (12), pp.e1296-e1308. ⟨10.1212/WNL.0000000000206774⟩
Journal articles hal-03963580v1

Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

Izanne Roos , Charles Malpas , Emmanuelle Leray , Romain Casey , Dana Horakova et al.
Neurology, 2022, 99 (17), pp.e1926-e1944. ⟨10.1212/WNL.0000000000201029⟩
Journal articles hal-03776286v1

Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study

D. A. Laplaud , L. Barbin , Chloé Rousseau , N. Jousset , Romain Casey et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.62--63
Journal articles hal-01259392v1

Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal

Fabien Rollot , Justine Couturier , Romain Casey , Sandrine Wiertlewski , Marc Debouverie et al.
Neurotherapeutics, 2022, 19 (2), pp.476-490. ⟨10.1007/s13311-022-01202-1⟩
Journal articles hal-03594074v1
Image document

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

Laetitia Barbin , Chloé Rousseau , Natacha Jousset , Romain Casey , Marc Debouverie et al.
Neurology, 2016, 86 (8), pp.771-778. ⟨10.1212/WNL.0000000000002395⟩
Journal articles hal-01299977v1
Image document

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France

Diane Pivot , Marc Debouverie , Michel Grzebyk , David Brassat , Michel Clanet et al.
PLoS ONE, 2016, 11 (12), pp.e0167556 (eCollection 2016). ⟨10.1371/journal.pone.0167556⟩
Journal articles inserm-01576154v1
Image document

First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study

Noëlle Lavandier , Mickaël Bonnan , Clarisse Carra-Dallière , Mahmoud Charif , Pierre Labauge et al.
Multiple Sclerosis and Related Disorders, 2019, 28, pp.309-312. ⟨10.1016/j.msard.2018.12.016⟩
Journal articles hal-02928079v1
Image document

Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome

Christine Lebrun-Frénay , Fabien Rollot , Lydiane Mondot , Helene Zephir , Celine Louapre et al.
JAMA Network Open, 2021, 4 (10), pp.e2128271. ⟨10.1001/jamanetworkopen.2021.28271⟩
Journal articles hal-03414579v1

Cognition and quality of life in clinically isolated syndrome patients starting a disease modifying therapy in the QUALICIS study may not predict treatment response at one year

M. Cohen , Bruno Brochet , Pierre Clavelou , Emmanuelle Le Page , Patrick Vermersch et al.
Journal of the Neurological Sciences, 2017, 382, pp.73-78. ⟨10.1016/j.jns.2017.09.030⟩
Journal articles hal-01614698v1
Image document

Determinants of Therapeutic Lag in Multiple Sclerosis

Izanne Roos , Emmanuelle Leray , Federico Frascoli , Romain Casey , J William L Brown et al.
Multiple Sclerosis Journal, 2021, 27 (12), pp.1838-1851. ⟨10.1177/1352458520981300⟩
Journal articles hal-03223056v1
Image document

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

David-Axel Laplaud , Romain Casey , Laetitia Barbin , Marc Debouverie , Jerome de Sèze et al.
Neurology, 2019, 93 (7), pp.e635-e646. ⟨10.1212/WNL.0000000000007938⟩
Journal articles inserm-02289153v1

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society

C. Lebrun , S. Vukusic , V. Abadie , C. Achour , F. Ader et al.
Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Journal articles hal-02546158v1

High and low efficacy therapy in secondary progressive multiple sclerosis after accounting for therapeutic lag

I. Roos , Emmanuelle Leray , Romain Casey , D. Horakova , E. Kubala Havrdova et al.
Multiple Sclerosis Journal, 2020, 26 (3_SUPPL), pp.534-535
Journal articles hal-03127244v1
Image document

Untreated patients with multiple sclerosis: A study of French expert centers

Xavier Moisset , Audrey-Anne Fouchard , Bruno Pereira , Frederic Taithe , Guillaume Mathey et al.
European Journal of Neurology, 2021, 28 (6), pp.2026-2036. ⟨10.1111/ene.14790⟩
Journal articles hal-03188971v1
Image document

Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study

Sarah Wilson , Floriane Calocer , Fabien Rollot , Mathieu Fauvernier , Laurent Remontet et al.
The Lancet Regional Health - Europe, 2023, 24, pp.100542. ⟨10.1016/j.lanepe.2022.100542⟩
Journal articles hal-03875120v1
Image document

The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

Johanna Andersen , Sifat Sharmin , Mathilde Lefort , Nils Koch-Henriksen , Finn Sellebjerg et al.
Multiple Sclerosis and Related Disorders, 2021, 53, pp.103012. ⟨10.1016/j.msard.2021.103012⟩
Journal articles hal-03268539v1
Image document

Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament-light chain in multiple sclerosis

Audrey Gauthier , Sébastien Viel , Magali Perret , Guillaume Brocard , Romain Casey et al.
Annals of Clinical and Translational Neurology, 2021, 8 (5), pp.1141-1150. ⟨10.1002/acn3.51355⟩
Journal articles hal-03216866v1

Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease

Roxana Ameli , Charles R.G. Guttmann , Juan Carlos Prieto , Fabien Rollot , Miklos Palotai et al.
Journal de Neuroradiologie / Journal of Neuroradiology, 2021, 48 (3), pp.170-175. ⟨10.1016/j.neurad.2019.03.015⟩
Journal articles hal-03538467v1
Image document

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study

Caroline Papeix , Giovanni Castelnovo , Emmanuelle Leray , Marc Coustans , Pierre Levy et al.
Neurology and Therapy, 2022, ⟨10.1007/s40120-022-00334-y⟩
Journal articles hal-03608016v1

Delay from treatment start to full effect of immunotherapies for multiple sclerosis

Izanne Roos , Emmanuelle Leray , Federico Frascoli , Romain Casey , J William L Brown et al.
Brain - A Journal of Neurology , 2020, 143 (9), pp.2742-2756. ⟨10.1093/brain/awaa231⟩
Journal articles hal-02955197v1

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

Sifat Sharmin , Mathilde Lefort , Johanna Balslev Andersen , Emmanuelle Leray , Dana Horakova et al.
CNS Drugs, 2021, 35 (11), pp.1217-1232. ⟨10.1007/s40263-021-00860-7⟩
Journal articles hal-03367246v1
Image document

Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis

Sophie Mathais , Xavier Moisset , Bruno Pereira , Frederic Taithe , Jonathan Ciron et al.
Neurotherapeutics, 2021, 18 (1), pp.378-386. ⟨10.1007/s13311-020-00926-2⟩
Journal articles hal-02995967v1
Image document

New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions

Stephane Kremer , Salem Hannoun , Fabrice Bonneville , Francoise Durand-Dubief , Thomas Tourdias et al.
Journal de Neuroradiologie / Journal of Neuroradiology, 2020, 47 (4), pp.250-258. ⟨10.1016/j.neurad.2020.01.083⟩
Journal articles hal-02570313v1
Image document

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study

Emmanuelle Leray , Sandra Vukusic , Marc Debouverie , Michel Clanet , Bruno Brochet et al.
PLoS ONE, 2015, 10 (7), pp.1-12. ⟨10.1371/journal.pone.0132033⟩
Journal articles hal-01201656v1

A French observational study about treatment failure under fingolimod in 91 multiple sclerosis patients

Clarisse Carra Dallière , M. Fisselier , M. Cohen , X. Ayrignac , Emmanuelle Le Page et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.701--702
Journal articles hal-01259397v1

Données IRM à long terme des patients sous tériflunomide : résultats de l’extension de l’étude de phase II

David K.B. Li , Anthony L. Traboulsee , Philippe Truffinet , Paul W. O’connor , Jean Pelletier et al.
Journées de Neurologie de langue française 2015, Mar 2015, Marseille, France. pp.A75, ⟨10.1016/j.neurol.2015.01.167⟩
Conference papers hal-01134975v1

MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial

Ayman Tourbah , Christine Lebrun-Frenay , Gilles Edan , M. Clanet , C. Papex et al.
Multiple Sclerosis Journal, 2015, 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN, OCT 07-10, 2015, 21 (11), pp.785
Journal articles hal-01259396v1